203 related articles for article (PubMed ID: 29663450)
1. Increased serum levels of IL-33 and soluble ST2 in neonates with human cytomegalovirus infection.
Chen Y; Qian J
J Med Virol; 2018 Aug; 90(8):1383-1388. PubMed ID: 29663450
[TBL] [Abstract][Full Text] [Related]
2. Serum soluble ST2 is a promising prognostic biomarker in HBV-related acute-on-chronic liver failure.
Jiang SW; Wang P; Xiang XG; Mo RD; Lin LY; Bao SS; Lu J; Xie Q
Hepatobiliary Pancreat Dis Int; 2017 Apr; 16(2):181-188. PubMed ID: 28381383
[TBL] [Abstract][Full Text] [Related]
3. Soluble ST2 and IL-33: Potential markers of endometriosis in the Tunisian population.
Mbarik M; Kaabachi W; Henidi B; Sassi FH; Hamzaoui K
Immunol Lett; 2015 Jul; 166(1):1-5. PubMed ID: 25977120
[TBL] [Abstract][Full Text] [Related]
4. Serum Soluble ST2 as a Novel Inflammatory Marker in Acute Ischemic Stroke.
Chen W; Lin A; Yu Y; Zhang L; Yang G; Hu H; Luo Y
Clin Lab; 2018 Sep; 64(9):1349-1356. PubMed ID: 30274001
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-33/ST2 signaling contributes to the severity of hemolytic uremic syndrome induced by enterohemorrhagic Escherichia coli.
Yamada S; Shimizu M; Kuroda M; Inoue N; Sugimoto N; Yachie A
Clin Exp Nephrol; 2019 Apr; 23(4):544-550. PubMed ID: 30467800
[TBL] [Abstract][Full Text] [Related]
6. Relevance of serum interleukin-33 and ST2 levels and the natural course of chronic hepatitis B virus infection.
Huan SL; Zhao JG; Wang ZL; Gao S; Wang K
BMC Infect Dis; 2016 May; 16():200. PubMed ID: 27180842
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of interleukin-33 and its soluble form receptor (sST2) are associated with cognitive performance in patients with schizophrenia.
de Campos-Carli SM; Miranda AS; Dias IC; de Oliveira A; Cruz BF; Vieira ÉL; Rocha NP; Barbosa IG; Salgado JV; Teixeira AL
Compr Psychiatry; 2017 Apr; 74():96-101. PubMed ID: 28126482
[TBL] [Abstract][Full Text] [Related]
8. The IL33/ST2 axis in Sjogren syndrome in relation to disease activity.
Margiotta DP; Navarini L; Vadacca M; Lo Vullo M; Pignataro F; Basta F; Afeltra A
Eur Rev Med Pharmacol Sci; 2016 Apr; 20(7):1295-9. PubMed ID: 27097949
[TBL] [Abstract][Full Text] [Related]
9. High Expression of Interleukin-33/ST2 Predicts the Progression and Poor Prognosis in Chronic Hepatitis B Patients with Hepatic Flare.
Yuan W; Mei X; Zhang YY; Zhang ZG; Zou Y; Zhu H; Liu Y; Wang JF; Qian ZP; Lu HZ
Am J Med Sci; 2020 Dec; 360(6):656-661. PubMed ID: 32988596
[TBL] [Abstract][Full Text] [Related]
10. Dysregulated Interleukin -33/ST2 Pathway Perpetuates Chronic Inflammation in Hashimoto's Thyroiditis.
Wang X; Shao X; Liu X; Qin Q; Xu J; Zhang JA
Endocr Metab Immune Disord Drug Targets; 2019; 19(7):1012-1021. PubMed ID: 30819087
[TBL] [Abstract][Full Text] [Related]
11. Predicting value of serum soluble ST2 and interleukin-33 for risk stratification and prognosis in patients with acute myocardial infarction.
Zhang K; Zhang XC; Mi YH; Liu J
Chin Med J (Engl); 2013; 126(19):3628-31. PubMed ID: 24112154
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of serum sST2 is associated with poor prognosis in acute-on-chronic hepatitis B liver failure.
Gao S; Huan SL; Han LY; Li F; Ji XF; Li XY; Fan YC; Wang K
Clin Res Hepatol Gastroenterol; 2015 Jun; 39(3):315-23. PubMed ID: 25481239
[TBL] [Abstract][Full Text] [Related]
13. Increased serum concentrations of soluble ST2 predict mortality after burn injury.
Hacker S; Dieplinger B; Werba G; Nickl S; Roth GA; Krenn CG; Mueller T; Ankersmit HJ; Haider T
Clin Chem Lab Med; 2018 Nov; 56(12):2079-2087. PubMed ID: 29949506
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of soluble urokinase plasminogen activator receptor, soluble ST2, and IL-33 in bronchopulmonary dysplasia.
Tunc T; Cekmez F; Yildirim S; Bulut O; Ince Z; Saldir M; Aydemir G; Yaman H; Coban A
Pediatr Res; 2014 Jun; 75(6):788-92. PubMed ID: 24603291
[TBL] [Abstract][Full Text] [Related]
15. Soluble ST2 is increased in systemic lupus erythematous and is a potential marker of lupus nephritis.
Moreau A; Nicaise C; Awada A; Soyfoo MS
Clin Exp Rheumatol; 2022 May; 40(5):897-903. PubMed ID: 34128798
[TBL] [Abstract][Full Text] [Related]
16. Elevations in Circulating sST2 Levels Are Associated With In-Hospital Mortality and Adverse Clinical Outcomes After Blunt Trauma.
Billiar IM; Guardado J; Abdul-Malak O; Vodovotz Y; Billiar TR; Namas RA
J Surg Res; 2019 Dec; 244():23-33. PubMed ID: 31279260
[TBL] [Abstract][Full Text] [Related]
17. [Diagnostic value of combining serum soluble ST2 and interleukin-33 for heart failure patients with preserved left ventricular ejection fraction].
Luo NS; Zhang HF; Liu PM; Lin YQ; Huang TC; Yang Y; Wang JF
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Mar; 45(3):198-203. PubMed ID: 28316175
[No Abstract] [Full Text] [Related]
18. Novel interleukin-33 and its soluble ST2 receptor as potential serum biomarkers in parotid gland tumors.
Sowa P; Misiolek M; Zielinski M; Mazur B; Adamczyk-Sowa M
Exp Biol Med (Maywood); 2018 May; 243(9):762-769. PubMed ID: 29763370
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-33/suppression of tumorigenicity 2 (IL-33/ST2) axis in idiopathic inflammatory myopathies and its association with laboratory and clinical parameters: a pilot study.
Opinc A; Sarnik J; Brzezińska O; Makowski M; Lewandowska-Polak A; Makowska J
Rheumatol Int; 2020 Jul; 40(7):1133-1141. PubMed ID: 32222805
[TBL] [Abstract][Full Text] [Related]
20. Soluble ST2 plasma concentrations predict mortality in HBV-related acute-on-chronic liver failure.
Lei Z; Mo Z; Zhu J; Pang X; Zheng X; Wu Z; Wang K; Li X; Xie D; Gao Z
Mediators Inflamm; 2015; 2015():535938. PubMed ID: 25892854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
